Skip to main content
Premium Trial:

Request an Annual Quote

XDx Licenses U. of Minnesota IP to Develop Lupus Dx

NEW YORK (GenomeWeb News) — XDx will in-license IP from the University of Minnesota that will enable the company to use gene expression technology to assess the status of systemic lupus erythematosus in patients, it said last week.
 
XDx also said it has entered a separate agreement with UM and the Feinstein Institute for Medical Research in New York that gives the company access to SLE patient samples taken from an NIH-funded study of biomarkers for autoimmune diseases.
 
The company plans to use these samples to in its work to develop lupus diagnostics.
 
Financial terms of the agreement were not released.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.